Clinical trial Recruiting at 8 sites Interventional Women only

Improving health outcomes for pregnant women in Kenya through STI testing

Official title: Improving Perinatal Outcomes Among Kenyan Pregnant Women With an Integrated STI Testing Model

Run by University of Washington · NCT06203951 · Data updated 2026-11-12

This study is testing different ways of checking for STIs during pregnancy to see which method helps improve the health of mothers and their babies in Kenya.

More HIV trials

Quick facts

Study typeInterventional
SexWomen only
Enrollment3132 (estimated)
SponsorUniversity of Washington
Academic / other
Locations8 sites (Homa Bay and 7 other locations)
StatusRecruiting
StartedJanuary 27, 2025
Main results expectedDecember 31, 2027
Study endsDecember 31, 2028
Registry record updatedJuly 16, 2025
Trial IDNCT06203951 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are cisgender women who are seeking antenatal services and are willing to participate in STI screening and testing.

Probably not a fit

Patients who are not seeking antenatal care or who do not identify as cisgender women may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of three different models of STI testing and management during antenatal care for pregnant women in Kisumu and Siaya, Kenya. A total of 3,132 participants will be randomly assigned to receive either standard-of-care management or enhanced STI testing using Xpert® assays, with follow-up through nine months postpartum. The study will assess various perinatal outcomes, including pregnancy loss, preterm birth, low birth weight, and neonatal death, to determine which testing model yields the best results for maternal and infant health.

Why it matters

Potential benefit: If successful, this study could lead to improved perinatal outcomes for pregnant women by identifying and treating STIs more effectively.

How similar studies have gone: Previous studies have shown promising results with enhanced STI testing approaches in similar populations, suggesting potential for success in this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Self-identifying as a cisgender woman
* Seeking antenatal services from the clinic
* Planning to receive antenatal and postnatal care at the clinic
* Willingness to receive syndromic STI screening and HIV/syphilis testing per national guidelines
* Able and willing to provide informed consent for participation

Exclusion Criteria:

* Male gender
* Not seeking antenatal services from the clinic
* Not planning to receive antenatal and postnatal care at the clinic
* Not willing to receive syndromic STI screening and HIV/syphilis testing per national guidelines
* Not able or willing to provide informed consent for participation

Where it's running

  • Homa Bay Teaching and Referral Hospital
    Homa Bay, Kenya
    Recruiting
  • Rachuonyo South Sub County Hospital
    Homa Bay, Kenya
    Recruiting
  • Rangwe Sub County Hospital
    Homa Bay, Kenya
    Recruiting
  • Chulaimbo County hospital
    Kisumu, Kenya
    Recruiting
  • Kisumu County Hospital
    Kisumu, Kenya
    Recruiting
  • Lumumba Sub County hospital
    Kisumu, Kenya
    Recruiting
Show 2 more locations
  • Migosi Sub County Hospital
    Kisumu, Kenya
    Recruiting
  • Yala sub County Hospital
    Yala, Kenya
    Recruiting

Study contacts

  • Principal investigator: Jillian Pintye, RN, MPH, PHD — University of Washington
  • Study coordinator: Lauren Gomez
  • Email: gomezL4@uw.edu
  • Phone: 206-685-5044

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.